Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016

Hidehisa Saeki, Takeshi Nakahara, Akio Tanaka, Kenji Kabashima, Makoto Sugaya, Hiroyuki Murota, Tamotsu Ebihara, Yoko Kataoka, Michiko Aihara, Takafumi Etoh, Norito Katoh

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The definitive diagnosis of AD requires the presence of all three features: (i) pruritus; (ii) typical morphology and distribution of the eczema; and (iii) chronic and chronically relapsing course. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.

Original languageEnglish
JournalJournal of Dermatology
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Practice Management
Atopic Dermatitis
Practice Guidelines
Eczema
Pruritus
Emollients
Evidence-Based Medicine
Tacrolimus
Ointments
Counseling
Japan
Adrenal Cortex Hormones
Guidelines
Psychology
Inflammation
Skin
Research
Therapeutics

Keywords

  • Atopic dermatitis
  • Clinical practice guideline
  • Diagnosis
  • Evidence-based medicine
  • Treatment

ASJC Scopus subject areas

  • Dermatology

Cite this

Saeki, H., Nakahara, T., Tanaka, A., Kabashima, K., Sugaya, M., Murota, H., ... Katoh, N. (Accepted/In press). Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016. Journal of Dermatology. https://doi.org/10.1111/1346-8138.13392

Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016. / Saeki, Hidehisa; Nakahara, Takeshi; Tanaka, Akio; Kabashima, Kenji; Sugaya, Makoto; Murota, Hiroyuki; Ebihara, Tamotsu; Kataoka, Yoko; Aihara, Michiko; Etoh, Takafumi; Katoh, Norito.

In: Journal of Dermatology, 2016.

Research output: Contribution to journalArticle

Saeki, H, Nakahara, T, Tanaka, A, Kabashima, K, Sugaya, M, Murota, H, Ebihara, T, Kataoka, Y, Aihara, M, Etoh, T & Katoh, N 2016, 'Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016', Journal of Dermatology. https://doi.org/10.1111/1346-8138.13392
Saeki, Hidehisa ; Nakahara, Takeshi ; Tanaka, Akio ; Kabashima, Kenji ; Sugaya, Makoto ; Murota, Hiroyuki ; Ebihara, Tamotsu ; Kataoka, Yoko ; Aihara, Michiko ; Etoh, Takafumi ; Katoh, Norito. / Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016. In: Journal of Dermatology. 2016.
@article{de0aea2c211241e997adf754e62eaa2e,
title = "Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016",
abstract = "Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The definitive diagnosis of AD requires the presence of all three features: (i) pruritus; (ii) typical morphology and distribution of the eczema; and (iii) chronic and chronically relapsing course. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.",
keywords = "Atopic dermatitis, Clinical practice guideline, Diagnosis, Evidence-based medicine, Treatment",
author = "Hidehisa Saeki and Takeshi Nakahara and Akio Tanaka and Kenji Kabashima and Makoto Sugaya and Hiroyuki Murota and Tamotsu Ebihara and Yoko Kataoka and Michiko Aihara and Takafumi Etoh and Norito Katoh",
year = "2016",
doi = "10.1111/1346-8138.13392",
language = "English",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016

AU - Saeki, Hidehisa

AU - Nakahara, Takeshi

AU - Tanaka, Akio

AU - Kabashima, Kenji

AU - Sugaya, Makoto

AU - Murota, Hiroyuki

AU - Ebihara, Tamotsu

AU - Kataoka, Yoko

AU - Aihara, Michiko

AU - Etoh, Takafumi

AU - Katoh, Norito

PY - 2016

Y1 - 2016

N2 - Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The definitive diagnosis of AD requires the presence of all three features: (i) pruritus; (ii) typical morphology and distribution of the eczema; and (iii) chronic and chronically relapsing course. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.

AB - Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The definitive diagnosis of AD requires the presence of all three features: (i) pruritus; (ii) typical morphology and distribution of the eczema; and (iii) chronic and chronically relapsing course. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.

KW - Atopic dermatitis

KW - Clinical practice guideline

KW - Diagnosis

KW - Evidence-based medicine

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84963858661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963858661&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.13392

DO - 10.1111/1346-8138.13392

M3 - Article

C2 - 27076388

AN - SCOPUS:84963858661

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

ER -